Recent evidence suggests that obesity is associated with increased levels of serotonin, also known as 5-hydroxytryptamine (5-HT), in the gut [12], and inhibiting serotonin could reduce obesity and its related disorders [13]. Here, HTR5A is linked to obesity disorder.